1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-H0030X |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Mononuclear Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Non-Hodgkin lymphoma |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Diseased Human Peripheral Blood Mononuclear Cells |
Human non-Hodgkin lymphoma (DLBCL) Peripheral Blood Mononuclear Cells are derived from the peripheral blood of patients with diffuse large B-cell lymphoma (DLBCL). DLBCL is an aggressive subtype of non-Hodgkin’s lymphoma originating from the germinal center. Morphologically, DLBCL cells can present in a variety of forms, such as centroblastic type and immunoblastic type. Diffuse large B-cell lymphoma (DLBCL) is marked by impaired B – cell receptor (BCR) signaling and the abnormal activation of crucial survival pathways, such as NF-κB, PI3K/Akt/mTOR, and JAK/STAT. These dysregulated pathways fuel unchecked cellular proliferation, impede apoptosis, and facilitate metabolic reprogramming towards aerobic glycolysis, thereby fulfilling the substantial energy requirements of the rapidly proliferating tumor cells.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
Human non-Hodgkin lymphoma (DLBCL) Peripheral Blood Mononuclear Cells can be used to study the pathogenesis of diseases. For example, by isolating malignant B cells, it is possible to analyze driving events such as abnormal BCR signaling pathways (such as persistent activation of NF-κB), epigenetic modifications (such as BCL6 super-enhancer mutations), etc. These cells can also be used for biomarker development.